Regeneron Pharma (REGN) PT Raised to $540 at Argus
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $808.46 +1.31%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Join SI Premium – FREE
Argus analyst Jasper Hellweg raised the price target on Regeneron Pharma (NASDAQ: REGN) to $540.00 (from $430.00) while maintaining a Buy rating.
You May Also Be Interested In
- Macquarie Upgrades Inventec Corp (2356:TT) to Neutral
- Godrej Consumer Products Ltd. (GCPL:IN) PT Lowered to INR1,150 at Macquarie
- Tingyi Cayman Islands Holding Corp. (322:HK) (TCYMY) PT Raised to HK$11.60 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
